A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Clinical trial NCT04252846 · COMPLETED

Trial details

NCT number: NCT04252846
Sponsor: Eisai Limited
Status: COMPLETED
Study type: OBSERVATIONAL

Idiopathic Generalized Epilepsy Partial Onset Seizures Generalised Tonic-Clonic Seizures

Start date: 2020-07-20
Primary completion: 2023-01-12
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.